Discovery of Flexible Naphthyltriazolylmethane-based Thioacetic Acids as Highly Active Uric Acid Transporter 1 (URAT1) Inhibitors for the Treatment of Hyperuricemia of Gout

Publisher： Bentham Science Publishers

E-ISSN： 1875-6638|13|3|260-281

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.13, Iss.3, 2017-04, pp. : 260-281

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chronic Hyperuricemia, Uric Acid Deposit and Cardiovascular Risk

By  

Current Pharmaceutical Design, Vol. 19, Iss. 13, 2013-04 ,pp. : 2432-2438

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of Glycine Transporter-1: Potential Therapeutics for the Treatment of CNS Disorders

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 29, 2016-12 ,pp. : 3404-3437

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis of ST7612AA1, a Novel Oral HDAC Inhibitor, via Radical Thioacetic Acid Addition

By  

Current Bioactive Compounds, Vol. 12, Iss. 4, 2016-12 ,pp. : 282-288

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Progress in the Discovery of Non-Sarcosine Based GlyT1 Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 2, 2010-02 ,pp. : 170-186

Bentham Science Publishers

Access to resources Recommend Favorite

The uric acid metabolism pathway as a therapeutic target in hyperuricemia related to metabolic syndrome

By Simão Andréa Name Colado   Lozovoy Marcell Alysson Batisti   Dichi Isaias  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 12, 2012-12 ,pp. : 1175-1187

Informa Healthcare

Access to resources Recommend Favorite